CD24 expression predicts disease progression in prostate cancer
This article has no abstract so we have provided the first paragraph of the full text.
As part of the search for new prognostic markers in prostate cancer, Kristiansen et al. have studied the expression of CD24, a small, glycosyl-phosphatidylinositol-linked cell surface protein thought to be involved in metastasis.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Prostate NewsProstate Cancer and Prostatic Diseases Research News
Metastases suppressors and prostate cancerNature Medicine News and Views (01 Aug 1995)